Live starting prices

#ozempic

9 articles tagged #ozempic.

Ready to compare providers? Take the 2-minute match quiz or see the cheapest GLP-1 options.

A single glass of water sitting still on a flat weathered oak table, morning light through sheer curtains, nothing in motion
AnalysisGuidesAugust 2, 20269 min read

Ozempic Plateau: Why You Stopped Losing Weight

A weight plateau on semaglutide or tirzepatide has four separate causes, and they do not share an answer. Here is how to tell which one you are looking at, using what the STEP and SURMOUNT trials actually measured.

Editorial lifestyle photograph illustrating a 2026 GLP-1 cost guide
AnalysisCost & InsuranceJuly 6, 202611 min read

GLP-1 Cost 2026: Wegovy, Zepbound & Ozempic Prices ($25 to $1,350/mo)

How much do GLP-1 medications cost in 2026? Wegovy, Zepbound, Ozempic, Mounjaro & Foundayo range from $25 to $1,350/month. With insurance + savings card: $25/mo. Without insurance: $146/mo compounded sema (Yucca Health), $149/mo Foundayo pill, $299 to 449/mo brand injectable (LillyDirect, NovoCare). Medicare: $50/mo, live as of July 2026. Prices verified July 2026 across 53 providers.

Editorial still-life illustrating an Ozempic versus Wegovy semaglutide comparison
AnalysisComparisonsJuly 2, 202618 min read

Ozempic vs Wegovy (2026): Same Drug, $1,028 vs $1,349 List, Here's Which You Need

Verified August 14, 2026: Ozempic and Wegovy are both semaglutide from Novo Nordisk. Ozempic ($1,027.51/mo list) is approved for type 2 diabetes at max 2mg. Wegovy ($1,349/mo list) is approved for weight loss at max 2.4mg (or 7.2mg HD). NovoCare lists each pen at $199/mo for the first two low-dose fills; Wegovy then costs $349/mo at standard strengths ($399 HD), while Ozempic costs $349/mo at 0.25-1mg or $499/mo at 2mg. Pills start at $149/mo and are dose-dependent.

Editorial still-life illustrating two parallel paths, a calm side-by-side comparison
AnalysisComparisonsJune 24, 202611 min read

Mounjaro vs Ozempic (2026): The Honest Head-to-Head Your Doctor Won't Have Time For

Mounjaro (tirzepatide) and Ozempic (semaglutide) are both FDA-approved only for type 2 diabetes, neither is approved for weight loss (that's their sister brands, Zepbound and Wegovy). In the first head-to-head trial, SURMOUNT-5, tirzepatide beat semaglutide for weight loss (−20.2% vs −13.7% over 72 weeks), and in SURPASS-2 tirzepatide cut A1C more. But Ozempic's semaglutide has the SELECT cardiovascular outcome data Mounjaro doesn't. Here's the data-driven breakdown, plus the cheaper cash-pay paths if your insurance says no.

Editorial still-life evoking metabolic balance and women's health, warm natural light
GuideCost & InsuranceJune 24, 202611 min read

GLP-1 for PCOS (2026): Ozempic, Wegovy & Cheaper Compounded Paths

GLP-1 medications like Ozempic and Wegovy can help PCOS because the syndrome is driven by insulin resistance, and these drugs improve insulin sensitivity, drive weight loss, and in trials restored menstrual regularity and raised natural-pregnancy rates. But here is the catch almost no one explains: PCOS by itself is NOT an FDA-approved reason to prescribe any GLP-1, so insurance and brand savings cards hinge on your BMI and comorbidities, not your PCOS diagnosis. This guide covers the trial signal, why insurance denies PCOS-only requests, the BMI rules behind savings cards, and the cheaper cash-pay paths if you do not qualify.

Featured Partners

Four affiliate partners we feature, we may earn a commission.

Embody

7.3/10
from $69/mo·Compounded

Gala

7.2/10
from $149/mo·Brand & Compounded

Ro

7.2/10
$149/mo membership + medication·Brand

Affiliate links, we earn a commission at no extra cost to you. These are featured partners, prioritized by our affiliate economics, not an editorial "best" ranking. The objective ranking (by methodology score) and full methodology are at glp1picks.com/best.